Stay updated on ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial
Sign up to get notified when there's something new on the ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial page.

Latest updates to the ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial page
- Check4 days agoChange DetectedA notice appears above the page describing an NIH website transition and the temporary use of both “Super Intelligence” and “Artificial Intelligence” terminology.SummaryDifference1%

- Check11 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check18 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check39 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the study record content. This indicates restricted access to the page, with the usual trial details replaced by an error message.SummaryDifference17%

- Check60 days agoChange DetectedA new line noting the 2017 U.S. NIH Grant/Contract was added to the study identifiers, and the page revision was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page now displays the new revision label v3.6.5, replacing the prior v3.6.4. This indicates a minor update to the page’s revision history without changing the study information shown.SummaryDifference0.1%

Stay in the know with updates to ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial page.